These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
773 related items for PubMed ID: 17395336
1. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain. Li Q, Lu G, Antonio GE, Mak YT, Rudd JA, Fan M, Yew DT. Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336 [Abstract] [Full Text] [Related]
2. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type. Roessner V, Sagvolden T, Dasbanerjee T, Middleton FA, Faraone SV, Walaas SI, Becker A, Rothenberger A, Bock N. Neuroscience; 2010 Jun 02; 167(4):1183-91. PubMed ID: 20211696 [Abstract] [Full Text] [Related]
3. Comparison of SHR, WKY and Wistar rats in different behavioural animal models: effect of dopamine D1 and alpha2 agonists. Langen B, Dost R. Atten Defic Hyperact Disord; 2011 Mar 02; 3(1):1-12. PubMed ID: 21432613 [Abstract] [Full Text] [Related]
4. Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder. Mc Fie S, Sterley TL, Howells FM, Russell VA. Brain Res; 2012 Jul 27; 1467():91-103. PubMed ID: 22658977 [Abstract] [Full Text] [Related]
5. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder]. Ueno K, Togashi H, Yoshioka M. Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb 27; 23(1):47-55. PubMed ID: 12690641 [Abstract] [Full Text] [Related]
7. Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder. Kantak KM, Singh T, Kerstetter KA, Dembro KA, Mutebi MM, Harvey RC, Deschepper CF, Dwoskin LP. Behav Neurosci; 2008 Apr 27; 122(2):340-57. PubMed ID: 18410173 [Abstract] [Full Text] [Related]
9. Spontaneously hypertensive and Wistar Kyoto rats differ in delayed matching-to-place performance and response to dietary long-chain polyunsaturated fatty acids. Clements KM, Girard TA, Xing HC, Wainwright PE. Dev Psychobiol; 2003 Jul 27; 43(1):57-69. PubMed ID: 12794779 [Abstract] [Full Text] [Related]
10. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder. van den Bergh FS, Bloemarts E, Chan JS, Groenink L, Olivier B, Oosting RS. Pharmacol Biochem Behav; 2006 Mar 27; 83(3):380-90. PubMed ID: 16580713 [Abstract] [Full Text] [Related]
11. N-methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder. Jensen V, Rinholm JE, Johansen TJ, Medin T, Storm-Mathisen J, Sagvolden T, Hvalby O, Bergersen LH. Neuroscience; 2009 Jan 12; 158(1):353-64. PubMed ID: 18571865 [Abstract] [Full Text] [Related]
12. Algorithmically designed peptides ameliorate behavioral defects in animal model of ADHD by an allosteric mechanism. Kinkead B, Selz KA, Owens MJ, Mandell AJ. J Neurosci Methods; 2006 Feb 15; 151(1):68-81. PubMed ID: 16423408 [Abstract] [Full Text] [Related]
14. Spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats differ in performance on a win-shift task in the water radial arm maze. Clements KM, Wainwright PE. Behav Brain Res; 2006 Feb 28; 167(2):295-304. PubMed ID: 16293322 [Abstract] [Full Text] [Related]
15. Differential effects of a selective dopamine D1-like receptor agonist on motor activity and c-fos expression in the frontal-striatal circuitry of SHR and Wistar-Kyoto rats. Diaz Heijtz R, Castellanos FX. Behav Brain Funct; 2006 May 26; 2():18. PubMed ID: 16729883 [Abstract] [Full Text] [Related]